Webinar: Streamlining Animal Health Research: CVM’s Expanded Conditional Approval Pathway Explained

On December 9th, Prelude CEO Tommy Jackson connected with Aaron Johnson, DVM, MS, Principal Regulatory Affairs Manager at Argenta connected to discuss real-world strategies you can use right now to streamline your timeline and prepare for smoother CVM interactions.

Check out the recorded session below to explore:

• How direct EDC access lets CVM review your study as it unfolds, removing the back-and-forth data handoffs that slow everything down.
• What Expanded Conditional Approval actually means for your timeline, and how earlier visibility into your data helps CVM move faster after LPI.
• What you can do today to be ready, from tightening up data standards to making sure your EDC is set for seamless CVM access.

The full recording is available above. We hope you enjoy!